Back to Journals » Neuropsychiatric Disease and Treatment » Volume 8

Review

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins

       
Total article views   HTML views PDF downloads Totals
12,133 Dovepress* 10,058+ 2,113 12,171
PubMed Central* 2,075 666 2,741
Totals 12,133 2,779 14,912
*Since 23 December 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar